Tye C, Runicles AK, Whitehouse AJ, Alvares GA. Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: an integrative review. Front Psychiatry. 2018. https://doi.org/10.3389/fpsyt.2018.00751.
McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133(5):872–83. https://doi.org/10.1542/peds.2013-3995.
Holingue C, Newill C, Lee L-C, Pasricha PJ, Daniele FM. Gastrointestinal symptoms in autism spectrum disorder: a review of the literature on ascertainment and prevalence. Autism Res. 2018;11(1):24–36. https://doi.org/10.1002/aur.1854.
Warreman EB, Nooteboom LA, Terry MB, Hoek HW, Leenen PJM, VanRossum EFC, et al. Psychological, behavioural and biological factors associated with gastrointestinal symptoms in autistic adults and adults with autistic traits. Autism. 2023. https://doi.org/10.1177/13623613231155324.
Article PubMed PubMed Central Google Scholar
Niesler B, Rappold GA. Emerging evidence for gene mutations driving both brain and gut dysfunction in autism spectrum disorder. Mol Psychiatry. 2021;26(5):1442–4. https://doi.org/10.1038/s41380-020-0778-5.
Mathew NE, Mallitt KA, Masi A, Katz T, Walker AK, Morris MJ, et al. Dietary intake in children on the autism spectrum is altered and linked to differences in autistic traits and sensory processing styles. Autism Res. 2022;15(10):1824–39. https://doi.org/10.1002/aur.2798.
Article PubMed PubMed Central Google Scholar
Yap CX, Henders AK, Alvares GA, Wood DLA, Krause L, Tyson GW, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916-31.e17. https://doi.org/10.1016/j.cell.2021.10.015.
Article CAS PubMed Google Scholar
Chakraborty P, Carpenter KLH, Major S, Deaver M, Vermeer S, Herold B, et al. Gastrointestinal problems are associated with increased repetitive behaviors but not social communication difficulties in young children with autism spectrum disorders. Autism. 2021;25(2):405–15. https://doi.org/10.1177/1362361320959503.
Restrepo B, Angkustsiri K, Taylor SL, Rogers SJ, Cabral J, Heath B, et al. Developmental–behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms. Autism Res. 2020;13(10):1778–89. https://doi.org/10.1002/aur.2354.
Article PubMed PubMed Central Google Scholar
Prosperi M, Santocchi E, Muratori F, Narducci C, Calderoni S, Tancredi R, et al. Vocal and motor behaviors as a possible expression of gastrointestinal problems in preschoolers with Autism Spectrum Disorder. BMC Pediatr. 2019;19(1):466. https://doi.org/10.1186/s12887-019-1841-8.
Article PubMed PubMed Central Google Scholar
Dovgan K, Gynegrowski K, Ferguson BJ. Bidirectional relationship between internalizing symptoms and gastrointestinal problems in youth with Autism Spectrum Disorder. J Autism Dev Disord. 2022. https://doi.org/10.1007/s10803-022-05539-6.
Al-Ayadhi L, Zayed N, Bhat RS, Moubayed NMS, Al-Muammar MN, El-Ansary A. The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review. Gut Pathogens. 2021;13(1):54. https://doi.org/10.1186/s13099-021-00448-y.
Article CAS PubMed PubMed Central Google Scholar
Kim JY, Choi MJ, Ha S, Hwang J, Koyanagi A, Dragioti E, et al. Association between autism spectrum disorder and inflammatory bowel disease: a systematic review and meta-analysis. Autism Res. 2022;15(2):340–52. https://doi.org/10.1002/aur.2656.
Kushak RI, Buie TM, Murray KF, Newburg DS, Chen C, Nestoridi E, et al. Evaluation of intestinal function in children with autism and gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2016;62(5):687–91. https://doi.org/10.1097/mpg.0000000000001174.
Pang T, Leach ST, Katz T, Day AS, Ooi CY. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2014;2:6. https://doi.org/10.3389/fped.2014.00006.
Article PubMed PubMed Central Google Scholar
Bromke MA, Neubauer K, Kempiński R, Krzystek-Korpacka M. Faecal calprotectin in assessment of mucosal healing in adults with inflammatory bowel disease: a meta-analysis. J Clin Med. 2021;10(10):2203. https://doi.org/10.3390/jcm10102203.
Article PubMed PubMed Central Google Scholar
Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, et al. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol. 2010;10:1–7. https://doi.org/10.1186/1471-230X-10-118.
Siddiqui I, Majid H, Abid S. Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World J Gastrointest Pharmacol Ther. 2017;8(1):39. https://doi.org/10.4292/wjgpt.v8.i1.39.
Article PubMed PubMed Central Google Scholar
Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate fecal biomarkers in inflammatory bowel disease: rivals or complementary tools of fecal calprotectin? Inflamm Bowel Dis. 2018;24(1):78–92. https://doi.org/10.1093/ibd/izx011.
Sherwood RA. Faecal markers of gastrointestinal inflammation. J Clin Pathol. 2012;65(11):981–5. https://doi.org/10.1136/jclinpath-2012-200901.
West KA, Yin X, Rutherford EM, Wee B, Choi J, Chrisman BS, et al. Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups. Sci Rep. 2022;12(1):17034. https://doi.org/10.1038/s41598-022-21327-9.
Article CAS PubMed PubMed Central Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. https://doi.org/10.7326/0003-4819-151-4-200908180-00135.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:1–13. https://doi.org/10.1186/1471-2288-14-135.
Whitehead SJ, French J, Brookes MJ, Ford C, Gama R. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits. Ann Clin Biochem. 2013;50(Pt 1):53–61. https://doi.org/10.1258/acb.2012.011272.
Article CAS PubMed Google Scholar
Labaere D, Smismans A, Van Olmen A, Christiaens P, D’Haens G, Moons V, et al. Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease. United Eur Gastroenterol J. 2014;2(1):30–7. https://doi.org/10.1177/2050640613518201.
Goll R, Heitmann R, Moe ØK, Carlsen K, Florholmen J. Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. PLoS ONE. 2019;14(12):e0224895. https://doi.org/10.1371/journal.pone.0224895.
Article CAS PubMed PubMed Central Google Scholar
Stedman A, Taylor B, Erard M, Peura C, Siegel M. Are children severely affected by autism spectrum disorder underrepresented in treatment studies? An analysis of the literature. J Autism Dev Disord. 2019;49(4):1378–90. https://doi.org/10.1007/s10803-018-3844-y.
Friedrich JO, Adhikari NKJ, Beyene J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008;8(1):32. https://doi.org/10.1186/1471-2288-8-32.
Article PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. https://doi.org/10.1002/sim.1186.
Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11(1):1–13. https://doi.org/10.1186/1471-230X-11-22.
Wang M, Wan J, Rong H, He F, Wang H, Zhou J, et al. Alterations in gut glutamate metabolism associated with changes in gut microbiota composition in children with autism spectrum disorder. mSystems. 2019;4(1):e0032118. https://doi.org/10.1128/mSystems.00321-18.
Fernell E, Fagerberg UL, Hellström PM. No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide. Acta Paediatr (Oslo, Norway: 1992). 2007;96(7):1076–9. https://doi.org/10.1111/j.1651-2227.2007.00298.x.
Zhou J, He F, Yang F, Yang Z, Xie Y, Zhou S, et al. Increased stool immunoglobulin A level in children with autism spectrum disorders. Res Dev Disabil. 2018;82:90–4. https://doi.org/10.1016/j.ridd.2017.10.009.
Wang M, Zhou J, He F, Cai C, Wang H, Wang Y, et al. Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders. Brain Behav Immun. 2019;75:192–9. https://doi.org/10.1016/j.bbi.2018.10.006.
Laghi L, Mastromarino P, Prosperi M, Morales MA, Calderoni S, Santocchi E, et al. Are fecal metabolome and microbiota profiles correlated with autism severity? A cross-sectional study on ASD preschoolers. Metabolites. 2021;11(10):654. https://doi.org/10.3390/metabo11100654.
留言 (0)